| 1 |
Han H, Li J, Santos HA. Recent advances in Fenton and Fenton-like reaction mediated nanoparticle in cancer therapy. Biomedical Technology 2023;3:40-51. [DOI: 10.1016/j.bmt.2022.12.004] [Reference Citation Analysis]
|
| 2 |
Zhang Q, Sun Z, Sun W, Yu B, Liu J, Jiang C, Lu L. Engineering a synergistic antioxidant inhibition nanoplatform to enhance oxidative damage in tumor treatment. Acta Biomater 2023;158:625-36. [PMID: 36608895 DOI: 10.1016/j.actbio.2022.12.067] [Reference Citation Analysis]
|
| 3 |
Lim XY, Capinpin SM, Bolem N, Foo ASC, Yip WG, Kumar AP, Teh DBL. Biomimetic nanotherapeutics for targeted drug delivery to glioblastoma multiforme. Bioengineering & Transla Med 2023. [DOI: 10.1002/btm2.10483] [Reference Citation Analysis]
|
| 4 |
Gerardi RM, Cannella R, Bonosi L, Vernuccio F, Ferini G, Viola A, Zagardo V, Buscemi F, Costanzo R, Porzio M, Giovannini EA, Paolini F, Brunasso L, Giammalva GR, Umana GE, Scarpitta A, Iacopino DG, Maugeri R. Forecasting Molecular Features in IDH-Wildtype Gliomas: The State of the Art of Radiomics Applied to Neurosurgery. Cancers (Basel) 2023;15. [PMID: 36765898 DOI: 10.3390/cancers15030940] [Reference Citation Analysis]
|
| 5 |
Mu M, Liang X, Zhao N, Chuan D, Chen B, Zhao S, Wang G, Fan R, Zou B, Han B, Guo G. Boosting ferroptosis and microtubule inhibition for antitumor therapy via a carrier-free supermolecule nanoreactor. J Pharm Anal 2023;13:99-109. [PMID: 36816538 DOI: 10.1016/j.jpha.2022.09.003] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 6 |
Yao Y, Ji P, Chen H, Ge J, Xu Y, Wang P, Xu L, Yan Z. Ferroptosis-based drug delivery system as a new therapeutic opportunity for brain tumors. Front Oncol 2023;13:1084289. [PMID: 36910646 DOI: 10.3389/fonc.2023.1084289] [Reference Citation Analysis]
|
| 7 |
Wang S, Zhang Y, Sun F, Xi K, Sun Z, Zheng X, Guo F, Zhong H, Yang M, Shao Y, Huang B, Dong M, Ni S, Sun L. Catalase-like Nanoenzymes Combined with Hydrogel to Facilitate Wound Healing by Improving the Microenvironment of Diabetic Ulcers. Materials & Design 2023. [DOI: 10.1016/j.matdes.2022.111557] [Reference Citation Analysis]
|
| 8 |
Chi H, Li B, Wang Q, Gao Z, Feng B, Xue H, Li G. Opportunities and challenges related to ferroptosis in glioma and neuroblastoma. Front Oncol 2023;13:1065994. [PMID: 36937406 DOI: 10.3389/fonc.2023.1065994] [Reference Citation Analysis]
|
| 9 |
Yu S, Chen L, Xu H, Long S, Jiang J, Wei W, Niu X, Li X. Application of nanomaterials in diagnosis and treatment of glioblastoma. Front Chem 2022;10:1063152. [PMID: 36569956 DOI: 10.3389/fchem.2022.1063152] [Reference Citation Analysis]
|
| 10 |
Fu Z, Zhang Y, Chen X, Wang N, Ma R, Luo X, Pan X, Yang Y, Xue W. A Versatile Nanoplatform Based on Metal‐Phenolic Networks Inhibiting Tumor Growth and Metastasis by Combined Starvation/Chemodynamic/Immunotherapy. Adv Funct Materials 2022. [DOI: 10.1002/adfm.202211869] [Reference Citation Analysis]
|
| 11 |
Kostryukova LV, Tereshkina YA, Tikhonova EG, Sanzhakov MA, Bobrova DV, Khudoklinova YY. [Study of the efficiency of cellular accumulation of doxorubicin supplied with a targeted delivery system based on phospholipid nanoparticles with integrin-directed peptide]. Biomed Khim 2022;68:437-43. [PMID: 36573410 DOI: 10.18097/PBMC20226806437] [Reference Citation Analysis]
|
| 12 |
Yang Q, Zhang W, Lu S, Cai X, Chen C, Zhang Q, Duan Y, Xie D, Zhang Q, Ran H, Liu H. Biodegradable doxorubicin-loaded ferric phosphate nanosheets for specific tumor elimination through autophagy inhibition-enhanced apoptosis/ferroptosis pathway. Chemical Engineering Journal 2022. [DOI: 10.1016/j.cej.2022.140455] [Reference Citation Analysis]
|
| 13 |
Zhang G, Fang Y, Li X, Zhang Z. Ferroptosis: A novel therapeutic strategy and mechanism of action in glioma. Front Oncol 2022;12:947530. [DOI: 10.3389/fonc.2022.947530] [Reference Citation Analysis]
|
| 14 |
Sivasoorian SS, Urade R, Chiu C, Wang L. Neuropeptide-Functionalized Gold Nanorod Enhanced Cellular Uptake and Improved In Vitro Photothermal Killing in LRP1-Positive Glioma Cells. Pharmaceutics 2022;14:1939. [DOI: 10.3390/pharmaceutics14091939] [Reference Citation Analysis]
|
| 15 |
Su S, Chen Y, Zhang P, Ma R, Zhang W, Liu J, Li T, Niu H, Cao Y, Hu B, Gao J, Sun H, Fang D, Wang J, Wang PG, Xie S, Wang C, Ma J. The role of Platinum(IV)-based antitumor drugs and the anticancer immune response in medicinal inorganic chemistry. A systematic review from 2017 to 2022. Eur J Med Chem 2022;243:114680. [PMID: 36152386 DOI: 10.1016/j.ejmech.2022.114680] [Reference Citation Analysis]
|
| 16 |
Zhuo S, He G, Chen T, Li X, Liang Y, Wu W, Weng L, Feng J, Gao Z, Yang K. Emerging role of ferroptosis in glioblastoma: Therapeutic opportunities and challenges. Front Mol Biosci 2022;9:974156. [DOI: 10.3389/fmolb.2022.974156] [Reference Citation Analysis]
|
| 17 |
Lu M, Zhou Y, Sun L, Shafi S, Ahmad N, Sun M, Dong J. The molecular mechanisms of ferroptosis and its role in glioma progression and treatment. Front Oncol 2022;12:917537. [DOI: 10.3389/fonc.2022.917537] [Reference Citation Analysis]
|
| 18 |
de Souza I, Ramalho MCC, Guedes CB, Osawa IYA, Monteiro LKS, Gomes LR, Rocha CRR. Ferroptosis Modulation: Potential Therapeutic Target for Glioblastoma Treatment. IJMS 2022;23:6879. [DOI: 10.3390/ijms23136879] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 19 |
Zhang D, Ren Y, He Y, Chang R, Guo S, Ma S, Guan F, Yao M. In situ forming and biocompatible hyaluronic acid hydrogel with reactive oxygen species-scavenging activity to improve traumatic brain injury repair by suppressing oxidative stress and neuroinflammation. Materials Today Bio 2022;15:100278. [DOI: 10.1016/j.mtbio.2022.100278] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 20 |
Fu H, Zhang Z, Li D, Lv Q, Chen S, Zhang Z, Wu M. LncRNA PELATON, a Ferroptosis Suppressor and Prognositic Signature for GBM. Front Oncol 2022;12:817737. [PMID: 35574340 DOI: 10.3389/fonc.2022.817737] [Reference Citation Analysis]
|
| 21 |
Foglizzo V, Marchiò S. Nanoparticles as Physically- and Biochemically-Tuned Drug Formulations for Cancers Therapy. Cancers (Basel) 2022;14:2473. [PMID: 35626078 DOI: 10.3390/cancers14102473] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 22 |
Geng H, Zhong QZ, Li J, Lin Z, Cui J, Caruso F, Hao J. Metal Ion-Directed Functional Metal-Phenolic Materials. Chem Rev 2022. [PMID: 35537069 DOI: 10.1021/acs.chemrev.1c01042] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 13.0] [Reference Citation Analysis]
|
| 23 |
Cao H, Yang L, Tian R, Wu H, Gu Z, Li Y. Versatile polyphenolic platforms in regulating cell biology. Chem Soc Rev 2022. [PMID: 35535743 DOI: 10.1039/d1cs01165k] [Cited by in Crossref: 30] [Cited by in F6Publishing: 29] [Article Influence: 30.0] [Reference Citation Analysis]
|
| 24 |
Fu X, Zhang Y, Zhang G, Li X, Ni S, Cui J. Targeted delivery of Fenton reaction packages and drugs for cancer theranostics. Applied Materials Today 2022;26:101353. [DOI: 10.1016/j.apmt.2021.101353] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 25 |
Chan MH, Huang WT, Satpathy A, Su TY, Hsiao M, Liu RS. Progress and Viewpoints of Multifunctional Composite Nanomaterials for Glioblastoma Theranostics. Pharmaceutics 2022;14:456. [PMID: 35214188 DOI: 10.3390/pharmaceutics14020456] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
|
| 26 |
Lazzarini A, Colaiezzi R, Galante A, Passacantando M, Capista D, Ferella F, Alecci M, Crucianelli M. Hybrid polyphenolic Network/SPIONs aggregates with potential synergistic effects in MRI applications. Results in Chemistry 2022;4:100387. [DOI: 10.1016/j.rechem.2022.100387] [Reference Citation Analysis]
|
| 27 |
Wang D, Fang W, Huang C, Chen Z, Nie T, Wang J, Luo L, Xiao Z. MR imaging guided iron-based nanoenzyme for synergistic Ferroptosis−Starvation therapy in triple negative breast cancer. Smart Materials in Medicine 2022;3:159-67. [DOI: 10.1016/j.smaim.2021.12.008] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
|
